Dinur, T.; Bauer, P.; Beetz, C.; Cozma, C.; Becker-Cohen, M.; Istaiti, M.; Rolfs, A.; Skrahina, V.; Zimran, A.; Revel-Vilk, S.
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease. Int. J. Mol. Sci. 2023, 24, 3945.
https://doi.org/10.3390/ijms24043945
AMA Style
Dinur T, Bauer P, Beetz C, Cozma C, Becker-Cohen M, Istaiti M, Rolfs A, Skrahina V, Zimran A, Revel-Vilk S.
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease. International Journal of Molecular Sciences. 2023; 24(4):3945.
https://doi.org/10.3390/ijms24043945
Chicago/Turabian Style
Dinur, Tama, Peter Bauer, Christian Beetz, Claudia Cozma, Michal Becker-Cohen, Majdolen Istaiti, Arndt Rolfs, Volha Skrahina, Ari Zimran, and Shoshana Revel-Vilk.
2023. "Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease" International Journal of Molecular Sciences 24, no. 4: 3945.
https://doi.org/10.3390/ijms24043945
APA Style
Dinur, T., Bauer, P., Beetz, C., Cozma, C., Becker-Cohen, M., Istaiti, M., Rolfs, A., Skrahina, V., Zimran, A., & Revel-Vilk, S.
(2023). Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease. International Journal of Molecular Sciences, 24(4), 3945.
https://doi.org/10.3390/ijms24043945